Document is current
Any future updates will be listed below
-
Authors
Hong, Seo Jung
Resnick, Samuel J https://orcid.org/0000-0003-1224-2114
Iketani, Sho https://orcid.org/0000-0002-3733-9556
Cha, Ji Won
Albert, Benjamin Alexander https://orcid.org/0000-0002-8989-077X
Fazekas, Christopher T
Chang, Ching-Wen https://orcid.org/0009-0006-0892-7419
Liu, Hengrui
Dagan, Shlomi
Abagyan, Michael R
Fajtová, Pavla
Culbertson, Bruce
Brace, Brooklyn https://orcid.org/0000-0001-5009-6125
Reddem, Eswar R
Forouhar, Farhad https://orcid.org/0000-0002-5571-7397
Glickman, J Fraser https://orcid.org/0000-0002-6706-4039
Balkovec, James M
Stockwell, Brent R https://orcid.org/0000-0002-3532-3868
Shapiro, Lawrence
O’Donoghue, Anthony J
Sabo, Yosef
Freundlich, Joel S
Ho, David D
Chavez, Alejandro https://orcid.org/0000-0001-5626-7140
-
Funding
Funding for this research was provided by:
HHS | National Institutes of Health (1U19AI1711401)
Burroughs Wellcome Fund (1017195.01)
jack ma foundation (N/A)
NSF | National Science Foundation Graduate Research Fellowship Program (DGE-2038238)
- License Information
-
More Information
Article History
Received: 12 May 2024
Revised: 30 November 2024
Accepted: 2 December 2024
First Online: 6 January 2025
Disclosure and competing interests statement
: AC, SJH, and SJR have submitted a patent related to the design and implementation of multiplex small molecule screens. BRS is an inventor on patents and patent applications involving small molecules, holds equity in and serves as a consultant to Exarta Therapeutics and ProJenX Inc., holds equity in Sonata Therapeutics, and serves as a consultant to Weatherwax Biotechnologies Corporation and Akin Gump Strauss Hauer & Feld LLP. DDH is a co-founder of TaiMed Biologics and RenBio, consultant to WuXi Biologics, Brii Biosciences, Apexigen, and Veru Inc., and board director for Vicarious Surgical.
